Low molecular weight (LMW) GTP-binding proteins are hypothesized to play a role in the vectorial transport of intracellular vesicles. Mutational studies in yeast and subcellular localization in mammalian cells suggest that a family of LMW GTP-binding proteins, termed rab, target intracellular vesicles to their appropriate acceptor compartment. In this report, we demonstrate that an elasmobranch homologue of rab3A, o-rab3, plays a significant role in the sequestration of regulated secretory vesicles. When transfected into the murine endocrine cell line AtT-20, the wild-type o-rab3 protein is localized exclusively to the tips of the processes, a region of the cell known to accumulate proteins associated with regulated secretory vesicles. Two mutations, Gln81 to Leu (Q81L) and Asn135 Ile (N135I), which alter GTP binding or rate of hydrolysis, blocked the localization of the o-rab3 protein to the tips of cell processes. These mutations also hindered the sequestration of ACTH-containing secretory vesicles to the process tips but did not affect the basal or stimulated release of ACTH. Moreover, the sequestration of the protein VAMP to the process tip was also hindered by the mutation. The results demonstrate a role for the rab3 proteins in localization, sequestration, and storage of secretory vesicles near their release site.
INTRODUCTION
Low molecular weight GTP-binding proteins have been proposed to act as molecular switches that regulate vectorial transport of intracellular vesicles (Bourne, 1988; Bourne et al., 1991) . Identified members of this class of GTP-binding proteins, commonly referred to as the rab subfamily of ras-like GTP-binding proteins, have grown substantially in recent years (Zahraoui et al., 1988; Chavrier et al., 1990b; Ngsee et al., 1991; Elferink et al., 1992) . Localization studies indicate that the rab proteins are associated with different intracellular membrane compartments. For example, rabl and 2 are localized to the endoplasmic reticulum (ER) and cis-Golgi compartment (Chavrier et al., 1990a) , rab3A to synaptic vesicles in neurons (Fischer von Mollard et al., 1990; Mizoguchi et al., 1990) , rab4, 5, and 7 to the endocytic compartments (Chavrier et al., 1990a ; Van Der Sluijs et al., 1991) , rab5B to the plasma membrane Wilson and Wilson, 1992) , and rab6 to the medial and trans-Golgi complex . This differential localization suggests that a specific rab protein regulates each transport step in the secretory pathway and justifies the existence of a large family of rab proteins. Further support is provided by the ability C) 1993 by The American Society for Cell Biology of specific rab antibodies to block the transport of vesicles from the early to the late endocytic compartments in vitro and the finding that transport of vesicles from the ER to the Golgi complex is irreversibly blocked by the addition of a synthetic peptide corresponding to a conserved region hypothesized to be the rab effector domain (Plutner et al., 1990) . Timecourse studies suggest that rab proteins act at a late stage of the transport process and may be coincident with a calcium-dependent prefusion step. However, the effects of effector domain peptides are not always inhibitory, as evidenced by the stimulatory effect of the rab effector domain peptide on amylase secretion in permeabilized pancreatic acinar cells (Padfield et al., 1992) and on changes in conductance in whole cell patched mast cells (Oberhauser et al., 1992) .
A proposed mechanism of rab protein action suggests that GTP-binding proteins cycle between donor and acceptor membrane compartments with subsequent hydrolysis of the bound GTP ensuring fidelity and vectorial transport (Boume, 1988; Balch, 1990; Goud et al., 1990) . This model predicts that inhibition of GTP hydrolysis would disrupt the vectorial targeting of transport vesicles. All GTP-binding proteins contain four highly conserved domains involved in the binding and hydrolysis of guanine nucleotide. A number of mutations in the ras protein are known to disrupt the interaction of the guanine nucleotide with the protein core and the hydrolysis of bound GTP. X-ray crystal structure of ras indicates that hydrolysis of the bound GTP involves a transition state complex (Prive et al., 1992) . Mutation of the Gly12 or Gln 6 residues have a destabilizing effect on this transition state and the coordination around the gamma phosphate group that can result in a drastically reduced rate of GTP hydrolysis (Grand et al., 1989; Tong et al., 1991; Prive et al., 1992) .
Other mutations, such as at the Ser17 and Asn12' residues, alter the association or dissociation rates of the guanine nucleotide thereby altering the activation state of the protein (Feig and Cooper, 1988; Krengel et al., 1990; Farnsworth and Feig, 1991; Tong et al., 1991) . Mutations that decrease the hydrolysis of GTP have been found to result in a constitutively activated ras protein (Barbacid, 1987) . These corresponding mutations have an inhibitory effect on the secretory process when introduced to the yeast Sec4p and Yptlp (Bacon et al., 1989; Walworth et al., 1989) . Because the rab proteins share significant homology to the yeast Sec4p and Yptlp, it is likely that these mutations will also exert an inhibitory effect on the secretory process mediated by the rab proteins.
A mutational approach was used to examine the functional role of rab proteins in vesicle trafficking. The marine ray Discopyge ommata o-rab3 protein shares 76-78% identity to the mammalian rab3 proteins (Volknandt et al., 1991) . Two missense mutations, Gln81 to Leu (Q81L) and Asn135 to Ile (N135I), predicted to alter the ability of o-rab3 to bind or hydrolyze GTP, were introduced into the conserved GTP-binding domains. These corresponding mutations in mammalian ras and yeast SEC4p result in a 10-fold decrease in GTPase activity and a fivefold increase in guanine nucleotide dissociation rate (Der et al., 1986; Barbacid, 1987; Grand et al., 1989; Kabcenell et al., 1990) . The corresponding N135I mutation in the yeast SEC4 protein results in a high guanine nucleotide off rate and a dose-dependent dominant lethal phenotype (Walworth et al., 1989) . The mouse anterior pituitary cell line, AtT-20 (Moore and Kelly, 1985) , was used as a model to test the effect of the mutated o-rab3 proteins. These cells exhibit a polarized morphology because synaptic-like vesicles, ACTH-containing dense core vesicles (DCVs), as well as proteins that undergo regulated secretion are localized to the tips of neuritic-like processes. The transfected orab3 genes were expressed under the control of the human metallothionein promoter (Karin et al., 1987) allowing controlled induction of the transfected gene product. We report that the mutation of o-rab3 alters its cellular localization. Moreover, the mutation disrupts the sequestration of DCVs at the tip of the process without significantly altering the basal and stimulated release of ACTH. 748
METHODS

Oligonucleotide-directed Mutagenesis and
Construction of pRc/hMT Expression Vector
The o-rab3 cDNA was subcloned into the EcoRI site of the KSII(-) Bluescript vector (Stratagene, La Jolla, CA). Oligonucleotide-directed mutagenesis (Kunkel, 1985) was used to generate the missense mutation. The sequence of the oligonucleotide for the Q81L mutation is 5'-ACTGCTGGCCTGGAGCGTTA-3' and for the N135I mutation is 5'-CTCGTTGGCATTAAATCGGAT-3'. The pRc/hMT expression vector was derived from the plasmid pRc/CMV (Invitrogen, San Diego, CA) by replacing the CMV promoter of pRc/CMV with the human metallothionein IIA (hMT) promoter from the plasmid pM2.7 (Karin et al., 1987) . The wild-type and Q81L mutant o-rab3 genes were subcloned into the HindIll and Xba I sites of the pRc/hMT vector. For Western blot analysis, the cells were either mock treated or induced with 10 MM CdCl2 for 48 h. The cells were washed off the plates with phosphate-buffered saline (PBS) containing 10 mM EDTA and lysed with 1% NP-40 in PBS. The cell debris was removed by centrifugation at 10 000 X g for 10 min, and 20 Mg of total cellular protein was analyzed on sodium dodecyl sulfate (SDS) polyacrylamide gel. The proteins were transferred onto nitrocellulose paper that was subsequently blocked with 5% skim milk in tris(hydroxymethyl)-aminomethane (Tris)-buffered saline. The o-rab3 protein was detected with affinity-purified antibodies. The bound antibodies were detected with histidine-rich protein-conjugated secondary antibodies via the enzyme-linked chemiluminescent (ECL) system (Amersham, Arlington Heights, IL). The primary antibody was raised in rabbit against a synthetic peptide, amino acids 189-208, corresponding to the variable carboxy terminal region of o-rab3. The antibody was affinity purified with the synthetic peptide coupled to Affi-Gel 102 (Bio-Rad, Richmond, CA).
For differential centrifugation studies, the o-rab3-transfected cells (10-cm plate) were induced with 10 ,M CdCl2 for 48 h and either mock treated or stimulated with 50 mM KCl for 10 min. The cells were harvested with ice-cold 10 mM EDTA in PBS and homogenized in 1 ml of buffer A (10 mM HEPES-KOH pH 7.4, 200 mM sucrose, 50mM NaCl, 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride). The cell debris was removed by centrifugation at 2500 X g for 10 min. The supernatant was then subjected to sequential differential centrifugation at 10 000 X g for 20 min, 24 000 X g for 20 min, and finally at 100 000 X g for 60 min. The pellet was washed with 0.5 ml of buffer A after each centrifugation step and resuspended in 0.2 ml of buffer A. Fifteen micrograms of protein from each fraction were subjected to Western blot analysis as described above. Figure 1B ). This microsomal fraction is enriched in ACTH-containing DCVs as well as a heterogeneous population of intracellular organelles. Because membrane localization of the rab proteins requires isoprenylation (Khosravi-Far et al., 1991; Kinsella and Maltese, 1992; Wei et al., 1992) , this indicates that the mutations have no effect on posttranslational modification and membrane localization.
Mutation of the o-rab3 Protein Alters Its Membrane Localization
The cellular localization of the transfected o-rab3 protein was detected by indirect immunocytochemistry and visualized using confocal microscopy. In cells transfected with the wild-type o-rab3, a low level of the protein can be detected at the tips of the processes in the absence of cadmium induction (Figure 2A) . A low level of expression was also seen in the Q81L and N1351 mutants (Figure 2, C and D) and is consistent with the properties of the human metallothionein promoter (Karin et al., 1987) . When induced with cadmium for 48 h, a significant increase in the amount of the protein was observed. The transfected wild-type o-rab3 protein remained exclusively at the tips under this enhanced expression ( Figure 2B ). The punctate appearance suggests association of the o-rab3 protein with intracellular vesicular membranes, consistent with the subcellular fractionation analysis. Unlike the wild-type o-rab3 protein, both mutant o-rab3 proteins failed to accumulate at the tips of the processes and remained in the cell body in a punctate-staining pattern (Figure 2, D and F) (Figure 3, A and B) . This indicates that increased expression of the transfected wildtype o-rab3 protein has a minimal effect on the final localization of ACTH-containing DCVs. In contrast, increased expression of the mutant o-rab3 exerted a profound effect on the distribution of ACTH-containing DCVs. In the absence of cadmium induction, both mutant o-rab3-transfected cells exhibited ACTH-containing DCVs at the tips and the Golgi complex similar to that seen in the wild-type o-rab3-transfected cells (Figure 3, C and E) . The level of ACTH accumulation at the tips was drastically reduced with enhanced expression of the mutant o-rab3 proteins (Figure 3, D and F) . This was accompanied by an increase in ACTH immunoreactivity in the region of the Golgi complex. This effect on ACTH accumulation was evident only with enhanced expression of the mutant o-rab3 proteins and indicates that mutation of the o-rab3 protein alters the sequestration of ACTH-containing DCVs at the tip in a dose-dependent manner. This also suggests that o-rab3 may be associated with this population of vesicles.
Quantitative Analysis of the Distribution of o-rab3 and ACTH in Stably Transfected To determine the extent of the effect of the o-rab3 mutations on the distribution of o-rab and ACTH, the pixel intensities at the different cellular regions were calculated from the digitized confocal microscopic images. Cells transfected with the wild-type o-rab3 genes exhibited approximately three times more orab3 protein per ,im at the process tips when induced with cadmium (Figure 4 ). This level of enhanced localization at the process tips was not seen with either of the mutant o-rab3 proteins. Whereas a modest increase in localization of the wild-type o-rab3 protein to the cell body was seen after cadmium induction, there was a two-to threefold increase in immunoreactivity in the cell body in the two mutant o-rab3-transfected cells. Vol. 4, July 1993 Enhanced expression of the wild-type o-rab3 protein has a minimal effect on the distribution of ACTH-containing DCVs (Figure 4) . In cells transfected with mutant o-rab3, a 30-40% reduction in the amount of ACTH immunoreactivity was observed upon cadmium induction. In the wild-type o-rab3-transfected cells, no net increase in ACTH immunoreactivity was observed in the Golgi complex after cadmium induction, whereas a 1.5-to twofold increase ACTH accumulation in the Golgi complex was seen in the two mutant o-rab3-transfected cells. Hence, mutation of the o-rab3 protein not only alters the distribution of the o-rab3 protein but also the sequestration of ACTH-containing DCVs to the tips in a dose-dependent manner.
Effect of Mutation of o-rab3 on the Distribution of Other Synaptic Vesicle Proteins
The effect of increased expression of o-rab3 proteins on the localization of other vesicle proteins endogenous to o-rab3 protein is localized to the process and enriched along the plasma membrane of the tip immediately after KCl depolarization ( Figure 6A ). Most of the wild-type o-rab3 remained along the process with some localization to intracellular membranes within the process tip during the 30 min recovery period ( Figure 6B ). In contrast, the mutant o-rab3 remained throughout the cell body upon stimulation ( Figure 6C ). The mutant o-rab3 also exhibits an altered pattern of distribution after stimulation. Whereas the wild-type protein remains at the process tip during the recovery period, the mutant o-rab3 appears to accumulate in the region of the transGolgi network (TGN) and the Golgi complex ( Figure  6D ). The same pattern was observed for the N1351 mutant (unpublished observation). This suggests that the wild-type protein recycles exclusively at the process tip and that the mutant o-rab3 in the cell body recycles through the TGN, possibly via an endocytic compartment.
Enhanced Expression of the Mutant o-rab3 Proteins
Has no Effect on Basal and Stimulated Secretion of ACTH The enhanced expression of mutant o-rab3 proteins appears to override the effect of an endogenous rab protein on the sequestration of ACTH-containing DCVs. To determine whether expression of mutant o-rab3 also altered regulated secretion, we measured the amount of pulse-labeled ACTH released into the medium under unstimulated and stimulated conditions. No significant difference was observed in the basal release of either precursor or processed ACTH between the wild-type and Q81L o-rab3-transfected cell lines (Table 1 ). In addition, no significant difference in ACTH release was seen after stimulation with the secretagogue, 8-BrcAMP. These data suggest that the mutation of o-rab3 has little or no direct effect on regulated or constitutive exocytosis and that the role of o-rab3 is limited to vesicle sequestration.
DISCUSSION
The mouse anterior pituitary tumor cell line, AtT-20, was used as a model to examine the localization and functional role of the D. ommata o-rab3 protein on intracellular vesicle trafficking. The wild-type and two mutant forms of o-rab3 were expressed under the control of the cadmium-inducible human metallothionein promoter. The inducibility of this promoter conveniently allows examination of the effect of increased expression of the mutant o-rab3 protein on intracellular vesicles. This is based on the assumption that increased expression of the mutant protein competes with the endogenous o-rab3 homologue for limiting components of the (Figure 2 ) that in AtT-20 cells are the storage sites for proteins secreted through the regulated secretory pathway (Moore and Kelly, 1985) . This region may also be functionally similar to the endings of neurite processes as a number of synaptic vesicle proteins, such as rab3A, VAMP, and SV2, are localized to this region of the cell. Thus, the localization of the wild-type orab3 protein in AtT-20 cells is consistent with its in vivo localization to the nerve terminals innervating the electric organ (Volknandt et al., 1993) and suggests that AtT-20 cells correctly recognize and sort the transfected wild-type protein. In contrast, the mutant o-rab3 proteins are distributed throughout the cell body in a sparse punctate pattern (Figure 2 ). This implies that GDP/GTP exchange and GTPase activity are required for proper localization or recycling. When stimulated with KCl and during the 30 min poststimulus recovery period, the wild-type protein remains along the plasma membrane of the process tip. However, the mutant o-rab3 proteins are distributed throughout the cell body after KCl stimulation and accumulate in the region of the TGN and Golgi complex during the recovery period. Thus, the mutant proteins may recycle between the plasma membrane and the TGN/Golgi complex, whereas the wildtype protein recycles locally within the process tip.
The altered distribution of the mutant o-rab3 protein also disrupts the distribution of a subset of regulated secretory vesicles. In cells transfected with the wildtype o-rab3, the ACTH-containing DCVs are sequestered at the tip of the process as well as in the Golgi complex. This distribution was not affected with increased expression of the wild-type o-rab3 protein. In cells transfected with mutant o-rab3, the ACTH-containing DCVs showed a normal distribution in the absence of cadmium induction. However, when induced 754 with cadmium, both mutant o-rab3-transfected cell lines exhibited a significant reduction in the amount of ACTH immunoreactivity at the process tips. This was accompanied by an increase in ACTH accumulation in the region of the Golgi complex. Thus, increased expression of the mutant o-rab3 proteins interferes with the localization and storage of ACTH-containing DCVs. However, the mislocalization of ACTH-containing DCVs does not appear to have a significant effect on the basal and stimulated release of the hormone. This is consistent with the observation that mislocalized chimeric Sec4p and Yptlp are capable of complementing their respective secretory defects (Brennwald and Novick, 1993; Dunn et al., 1993) . Therefore, it is possible that mislocalized ACTH-containing vesicles are released from sites in the cell body, thereby bypassing the storage step at the process tips.
Despite the similarity in the primary sequence between o-rab3 and the mammalian rab3A, the distribution of the endogenous rab3A was not severely affected by the increased expression of the mutant o-rab3 proteins. This lack of effect suggests that rab3A and orab3 are targeted to or sorted into distinct intracellular membrane compartments. Comparison of the primary sequence between the two proteins indicates significant divergence at the hypervariable carboxy terminal domain. This region of the protein is thought to contain the targeting or localization signal for the rab family of GTP-binding proteins (Chavrier et al., 199 1; Brennwald and Novick, 1993; Dunn et al., 1993) . Therefore, it is likely that an endogenous rab3A is involved in regulating the small synaptic-like vesicles and that in AtT-20 cells the o-rab3 homologue is associated with the large DCVs.
Increased expression of the mutated o-rab3 protein selectively alters the distribution of VAMP, a protein commonly associated with synaptic vesicles (Trimble et al., 1988; Baumert et al., 1989) and regulated secretory vesicles in adipocytes (Cain et al., 1992) . Genetic analysis in yeast indicates that the VAMP-like proteins Slyl2p/ Betlp and Sly2p/Sec22p (Newman et al., 1990; Dascher et al., 1991) A number of explanations for the decreased accumulation of ACTH-containing DCVs at the tip in the mutant o-rab3-transfected cells were considered. Mutation of o-rab3 might alter the processing of the POMC precursor resulting in diversion of ACTH to the degradative path. However, pulse-chase studies revealed no detectable difference in the processing rate of the POMC precursor (unpublished observation). Another possibility is that the decrease in accumulation of ACTH-containing DCVs at the tips of mutant o-rab3-transfected cells is a consequence of rerouting of the ACTH-containing DCVs from the regulated to the constitutive secretory pathway or that DCVs reaching the process tips may be secreted by a new pathway. The predicted outcome of this scenario is an increase in the basal release of the hormone. However, no significant difference was observed in the basal release of either precursor or processed ACTH between the wild-type and mutant o-rab3-transfected cell lines. A third possibility is that the mutant o-rab3 proteins interfere with the transport of ACTH-containing DCVs down the extended process to the tip. For example, the o-rab3 protein may be required for the stable interaction between the DCVs and the microtubule-based transport machinery. Mutations of the rab protein may destabilize this interaction resulting in premature interruption of the transport process. This remains a viable possibility and secretion of ACTH would not be severely affected because regulated secretion is known to occur in the cell body in AtT-20 cells.
The data presented here suggest that the o-rab3 protein most likely associates with ACTH-containing regulated secretory vesicles and mediates their sequestration at the process tip. In the presence of a functional o-rab3 protein, vesicles arriving at the tip of the process are effectively sequestered perhaps by associating with pre-existing cytoskeletal elements or through assembly of a sequestration complex. The hydrolysis of GTP would provide the signal for recruitment of proteins that constitute this complex and make this process irreversible. The data further suggest that after stimulated secretion, the wild-type protein is recycled locally at the process tip and reassociates with newly arriving ACTHcontaining secretory vesicles. In the mutant o-rab3 background, the premature dissociation of GTP or a kinetic delay in the hydrolysis of the bound GTP may abort the sequestration process. This would increase the likelihood of retrieval and/or retrograde transport of the DCVs to the cell body. Upon stimulation of cells transfected with the mutant o-rab3, the DCVs are re- Vol. 4, July 1993 leased at the cell body, and the mutant proteins may be recycled through a TGN or Golgi compartment. Hence, the cell process tips may be considered a reservoir for regulated secretory vesicles, and the primary role of the o-rab3 protein is to regulate the sequestration of mature secretory vesicles at this site. The cellular localization of o-rab3 and the phenotype we observed makes it likely that rab proteins may be important in regulating protein interactions with the cytoskeletal network as well as the vesicle membrane.
